Catalyst Wire Dossier Catalyst Wire Dossier

Donepezil hydrochloride 23 mg

donepezil hydrochloride · Eisai Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donepezil hydrochloride 23 mg, covering 2023-06-18 to 2023-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease [Phase 3]

See pricing